Date Filed | Type | Description |
07/06/2023 |
4
| Ticho Barry (Chief Medical Officer) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Sold 15,000 shares
@ $10.5982, valued at
$159k
|
|
06/15/2023 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
06/15/2023 |
4
| Smith Julie (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
06/15/2023 |
4
| Menzel Garry E (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
06/15/2023 |
4
| LEVIN ARTHUR A (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
06/15/2023 |
4
| Krainer Adrian R. (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
06/15/2023 |
4
| Harrison Seth Loring (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
06/15/2023 |
4
| Burstein Jennifer (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
06/05/2023 |
4
| Ticho Barry (Chief Medical Officer) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Sold 15,000 shares
@ $11.1309, valued at
$167k
|
|
05/08/2023 |
4
| Ticho Barry (Chief Medical Officer) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Sold 653 shares
@ $10, valued at
$6.5k
|
|
05/03/2023 |
4
| Ticho Barry (Chief Medical Officer) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Sold 24,967 shares
@ $10.0039, valued at
$249.8k
Sold 5,513 shares
@ $10.0007, valued at
$55.1k
Sold 24,697 shares
@ $10.1375, valued at
$250.4k
|
|
03/17/2023 |
4
| Allan Jonathan (General Counsel & Corp Sec) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 44,800 options to buy
@ $9.15, valued at
$409.9k
Granted 29,900 restricted stock units
@ $0 |
|
03/17/2023 |
4
| Tulipano Stephen J (CFO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 78,600 options to buy
@ $9.15, valued at
$719.2k
Granted 52,400 restricted stock units
@ $0 |
|
03/17/2023 |
4
| Ticho Barry (Chief Medical Officer) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 78,600 options to buy
@ $9.15, valued at
$719.2k
Granted 52,400 options to buy
@ $0 |
|
03/17/2023 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 78,600 options to buy
@ $9.15, valued at
$719.2k
Granted 52,400 restricted stock units
@ $0 |
|
03/17/2023 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 213,000 options to buy
@ $9.15, valued at
$1.9M
Granted 142,000 restricted stock units
@ $0 |
|
03/17/2023 |
3
| Allan Jonathan (General Counsel & Corp Sec) has filed a Form 3 on Stoke Therapeutics, Inc. |
02/07/2023 |
4
| Ticho Barry (Chief Medical Officer) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Sold 3,763 shares
@ $10.0306, valued at
$37.7k
Sold 9,235 shares
@ $10.0153, valued at
$92.5k
|
|
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2022 |
4
| LEVIN ARTHUR A (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 21,000 options to buy
@ $12.96, valued at
$272.2k
|
|
06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2022 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Exercised 15,000 options to buy
@ $0.6, valued at
$9k
|
|
03/17/2022 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 308,000 options to buy
@ $20.34, valued at
$6.3M
|
|
03/17/2022 |
4
| Tulipano Stephen J (CFO) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns:
| Granted 107,400 options to buy
@ $20.34, valued at
$2.2M
|
|
|